STOCK TITAN

USANA Health Sciences Reports First Quarter Results

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

USANA Health Sciences reported strong financial results for Q1 2021, with a 15.5% year-over-year increase in net sales to $308.0 million and a 17.9% rise in diluted EPS to $1.45.

The company repurchased 721,000 shares for $69.5 million and raised its 2021 outlook for net sales and diluted EPS. Active customers grew 7.7% to 617,000, showing strong demand across all regions, particularly in Asia Pacific.

Positive
  • Net sales up 15.5% year-over-year to $308.0 million.
  • Diluted EPS increased 17.9% year-over-year to $1.45.
  • Share repurchase of 721,000 shares for $69.5 million.
  • Raised outlook for 2021 net sales and diluted EPS.
  • Active customers rose 7.7% to 617,000.
Negative
  • Active customer count in Greater China decreased by 0.4%.

USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal first quarter ended April 3, 2021.

Key Financial & Operating Highlights

  • First quarter net sales increased 15.5% year-over-year to $308.0 million.
  • First quarter diluted EPS increased 17.9% year-over-year to $1.45.
  • Repurchased 721,000 shares for $69.5 million during the quarter.
  • Raises 2021 net sales and diluted EPS outlook.

Q1 2021 Financial Performance

Consolidated Results

Net Sales

$308.0 million

  • +15.5% vs. prior-year quarter
  • +9.3% constant currency vs. prior-year quarter
  • +$16.6 million YOY FX impact, or +6.2%

Diluted EPS

$1.45

  • +17.9% vs. prior-year quarter
  • Diluted shares of 21.1 million, -2.1%

Active Customers

617,000

  • +7.7% vs. prior-year quarter

“We had an excellent start to the year largely due to continued strong consumer demand for our high-quality products,” said Kevin Guest, Chief Executive Officer and Chairman of the Board. “Our strong top-line performance was driven by double-digit year-over-year sales growth in each of our regions, and we expect the execution of our 2021 global growth strategy will continue to generate growth in the remainder of the year.”

Q1 2021 Regional Results:

Asia Pacific Region

Net Sales

$251.3 million

  • +16.6% vs. prior-year quarter
  • Constant currency net sales: +9.3%
  • 81.6% of consolidated net sales

Active Customers

472,000

  • +5.1% vs. prior-year quarter

Asia Pacific Sub-Regions

Greater China

Net Sales

$149.0 million

  • +13.3% vs. prior-year quarter
  • Constant currency net sales: +5.9%

Active Customers

276,000

  • -0.4% vs. prior-year quarter
  • +9.5% sequentially

North Asia

Net Sales

$30.2 million

  • +10.7% vs. prior-year quarter
  • Constant currency net sales:

FAQ

What are USANA's financial results for Q1 2021?

USANA reported a net sales increase of 15.5% year-over-year to $308.0 million and diluted EPS increased by 17.9% to $1.45.

How much did USANA repurchase in shares during Q1 2021?

USANA repurchased 721,000 shares for a total of $69.5 million during the quarter.

What is the outlook for USANA in 2021?

USANA raised its outlook for net sales and diluted EPS for the year 2021.

How many active customers does USANA have as of Q1 2021?

As of Q1 2021, USANA has 617,000 active customers, which is a 7.7% increase from the previous year.

What was the performance of USANA in the Greater China region?

In Greater China, USANA's active customer count decreased by 0.4% year-over-year, while net sales increased by 13.3%.

USANA Health Sciences Inc

NYSE:USNA

USNA Rankings

USNA Latest News

USNA Stock Data

725.03M
11.09M
41.71%
57.62%
2.71%
Packaged Foods
Medicinal Chemicals & Botanical Products
Link
United States of America
SALT LAKE CITY